Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge
| Autor: | Ewa Wallin, Robert Frithiof, Emil Ekbom, Christer Janson, Michael Hultström, Miklos Lipcsey, Andrei Malinovschi, Larson Im, Emilsson Öi, Sten Rubertsson |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pulmonary and Respiratory Medicine
Spirometry ARDS Time Factors Coronavirus disease 2019 (COVID-19) Post discharge Respiratory Medicine and Allergy Short Communication Critical Illness medicine.medical_treatment Pulmonary function testing 03 medical and health sciences 0302 clinical medicine DLCO Diffusing capacity medicine Humans ICU treatment 030212 general & internal medicine Diffusion capacity Lung Lungmedicin och allergi Mechanical ventilation Carbon Monoxide medicine.diagnostic_test SARS-CoV-2 business.industry COVID-19 Follow up medicine.disease Lung function Patient Discharge 030228 respiratory system Anesthesia Pulmonary Diffusing Capacity business |
| Zdroj: | Respiratory Medicine |
| ISSN: | 0954-6111 |
| DOI: | 10.1016/j.rmed.2021.106394 |
| Popis: | There is limited knowledge about the long-term effects on pulmonary function of COVID-19 in patients that required intensive care treatment. Spirometry and diffusing capacity for carbon monoxide (DLCO) were measured in 60 subjects at 3-6 months post discharge. Impaired lung function was found in 52% of the subjects, with reduced DLCO as the main finding. The risk increased with age above 60 years, need for mechanical ventilation and longer ICU stay as well as lower levels of C-reactive protein at admission. This suggests the need of follow-up with pulmonary function testing in intensive-care treated patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect